No. Sildenafil, a component of Malegra FXT, can cause severe and potentially life-threatening low blood pressure when combined with nitrates. This combination is absolutely contraindicated.
Excessive alcohol can worsen the blood-pressure-lowering effect of sildenafil and increase fluoxetine-related sedation. Moderate consumption may be tolerated, but it is safest to limit alcohol around the time you take the medication.
A prolonged erection (priapism) is a medical emergency. Seek immediate care at the nearest emergency department; timely treatment helps prevent permanent damage.
Both formulations are round, film-coated pills, but the imprint code may differ to indicate the fluoxetine strength. Check the packaging for the exact imprint and verify with your pharmacist.
Older men often have concurrent cardiovascular or metabolic conditions that increase the risk of side effects. Starting with the lowest possible dose and close monitoring of blood pressure and mood are recommended.
Combining fluoxetine with another SSRI can raise the risk of serotonin syndrome. Such combinations should only be considered under specialist supervision, with dose adjustments as necessary.
Fluoxetine treats depressive and anxiety disorders, which are common psychological contributors to erectile dysfunction. Improving mood and reducing performance anxiety may indirectly enhance sexual performance.
Yes. A high-fat meal can slow the absorption of sildenafil, potentially delaying its peak effect by up to an hour. Taking the tablet on an empty stomach may provide a quicker response.
Fluoxetine can prolong the QT interval, especially when combined with other QT-lengthening drugs such as certain antipsychotics. Patients with known cardiac arrhythmias should be evaluated carefully before use.
Keep the tablets in their original container, sealed, and stored at room temperature away from direct sunlight. Avoid exposing them to extreme temperatures, such as in a hot car or freezer, to maintain potency.
Malegra FXT is a combination pill that contains two active ingredients: sildenafil and fluoxetine. Sildenafil is a phosphodiesterase-type 5 (PDE5) inhibitor that is widely used to treat erectile dysfunction (ED). Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that is licensed for the treatment of depression, obsessive-compulsive disorder and several other mood-related conditions. Malegra FXT is marketed in the United Kingdom as a 100 mg/40 mg or 100 mg/60 mg tablet, but it does not have a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for any specific indication. Consequently, the clinical information presented here is based on the well-established properties of its individual components.
Sildenafil blocks the enzyme PDE5, which normally breaks down cyclic guanosine monophosphate (cGMP) in the smooth muscle of the penis. By inhibiting PDE5, sildenafil increases cGMP levels, allowing the smooth muscle to relax, blood vessels to dilate, and an erection to occur in response to sexual stimulation. The onset of action is usually 30-60 minutes, with a peak effect around 1 hour and a duration of up to 4 hours.
Fluoxetine enhances serotonergic neurotransmission by selectively inhibiting the re-uptake of serotonin (5-HT) into presynaptic neurons. This increases the amount of serotonin available in the synaptic cleft, helping to improve mood, reduce anxiety, and, in some cases, alleviate psychogenic contributors to erectile dysfunction. Fluoxetine has a long half-life (about 4-6 days), which leads to steady-state concentrations after about 4-5 weeks of daily dosing.
When combined, the two agents address both vascular and psychological components that can affect sexual performance. However, no regulatory body has formally approved this combination, and the evidence for synergistic benefit remains limited.
Sildenafil is an MHRA-approved first-line therapy for erectile dysfunction. It is indicated for adult men who are able to engage in sexual activity and have no contraindications to PDE5 inhibition.
Fluoxetine is not approved for the treatment of erectile dysfunction. Its primary approved uses in the UK include major depressive disorder, obsessive-compulsive disorder, panic disorder, and bulimia nervosa.
Malegra FXT as a fixed-dose combination does not have an approved indication. Health-care professionals may prescribe the individual components separately when both a vascular cause of ED and a mood disorder coexist, but the combination product itself must be prescribed in accordance with local clinical judgement and patient-specific risk assessment.
These effects are usually mild and transient; they often diminish with continued therapy.
Patients experiencing any of these symptoms should seek immediate medical attention.
Patients should provide a full medication list, including over-the-counter drugs and herbal supplements, before starting Malegra FXT.
This article provides educational information about Malegra FXT and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
